Table 5 This table shows Logistic regression analysis for 30 day survival

1

-No AKI

1

<0.001

-AKIN 1

11.4 (7.98, 16.3)

-AKIN 2

88.7 (54.4, 145)

-AKIN 3

173 (98.7, 302)

2

-No AKI

1

<0.001

-AKIN 1

6.74 (4.67, 9.72)

-AKIN 2

58.9 (35.4, 98.0)

-AKIN 3

158 (87.0, 288)

Female sex

0.69 (0.50, 0.95)

<0.001

Age ^(*)

-Linear term

0.61 (0.22, 1.67)

<0.001

-Squared term

1.09 (1.02, 1.18)

3

-No AKI

1

<0.001

-AKIN 1

5.42 (3.67, 8.00)

-AKIN 2

39.8 (22.8, 69.6)

-AKIN 3

185 (94.0, 365)

Female sex

0.67 (0.48, 0.94)

0.02

Age ^(*)

-Linear term

0.39 (0.14, 1.10)

<0.001

-Squared term

1.13 (1.06, 1.22)

Any malignancy

3.68 (2.36, 5.74)

<0.001

CHF

2.16 (1.29, 3.65)

0.004

CPD

1.00 (0.59, 1.69)

1.00

Cerebrovascular disease

0.54 (0.27, 1.08)

0.08

Dementia

4.87 (2.50, 9.47)

<0.001

Diabetes

1.21 (0.77, 1.89)

0.42

Hemiplegia or paraplegia

2.94 (0.96, 9.01)

0.06

Hypertension

1.14 (0.79, 1.66)

0.48

MI

0.82 (0.41, 1.64)

0.57

Solid tumour

7.55 (4.20, 13.6)

<0.001

Mild liver disease

2.28 (0.83, 6.32)

0.11

PVD

1.21 (0.60, 2.43)

0.60

Peptic ulcer

2.89 (1.05, 7.98)

0.04

Renal disease

0.46 (0.23, 0.91)

0.03

Rheumatic disease

0.56 (0.19, 1.59)

0.28

Missing data

1.52 (0.87, 2.67)

0.14

GFR > 60

1

0.78

GFR 45 - < 60

0.82 (0.53, 1.26)

GFR 30 - < 45

0.83 (0.49, 1.42)

GFR < 30

0.85 (0.38, 1.89)

4

-No AKI

1

<0.001

-AKIN 1

5.26 (3.57, 7.74)

-AKIN 2

36.8 (21.6, 62.7)

-AKIN 3

123 (64.8, 235)

Female sex

0.74 (0.53, 1.02)

0.07

Age ^(*)

-Linear term

0.52 (0.19, 1.42)

<0.001

-Squared term

1.10 (1.03, 1.18)

Charlson

-≤0

1

<0.001

-1-10

2.67 (1.59, 4.49)

-11+

5.24 (3.25, 8.44)

-No info

2.05 (1.11, 3.79)

GFR > 60

1

0.03

GFR 45 - < 60

0.65 (0.43, 1.00)

GFR 30 - < 45

0.63 (0.38, 1.06)

GFR < 30

0.42 (0.20, 0.92)